Search Results - "McIntosh, JK"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth by LIANG YOU, BIAO HE, MCCORMICK, Frank, JABLONS, David M, ZHIDONG XU, UEMATSU, Kazutsugu, MAZIERES, Julien, FUJII, Naoaki, MIKAMI, Iwao, REGUART, Noemi, MCINTOSH, Joe K, KASHANI-SABET, Mohammed

    Published in Cancer research (Chicago, Ill.) (01-08-2004)
    “…Activation of the Wnt/beta-catenin signaling pathway has been associated with human cancers. To test whether Wnt-2 signal is a survival factor in human…”
    Get full text
    Journal Article
  2. 2

    Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses by Ghansah, Tomar, Paraiso, Kim H. T, Highfill, Steven, Desponts, Caroline, May, Sarah, McIntosh, Joseph K, Wang, Jia-Wang, Ninos, John, Brayer, Jason, Cheng, Fengdong, Sotomayor, Eduardo, Kerr, William G

    Published in The Journal of immunology (1950) (15-12-2004)
    “…Previously we demonstrated that SHIP(-/-) mice accept allogeneic bone marrow transplants (BMT) without significant acute graft-vs-host disease (GvHD). In this…”
    Get full text
    Journal Article
  3. 3

    Antitumor activity of recombinant interleukin 6 in mice by MULE, J. J, MCINTOSH, J. K, JABLONS, D. M, ROSENBERG, S. A

    Published in The Journal of experimental medicine (01-03-1990)
    “…IL-6 possesses multiple biologic activities that affect a broad range of cells including those directly involved in immune responses as well as cells important…”
    Get full text
    Journal Article
  4. 4

    IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans by Jablons, DM, Mule, JJ, McIntosh, JK, Sehgal, PB, May, LT, Huang, CM, Rosenberg, SA, Lotze, MT

    Published in The Journal of immunology (1950) (01-03-1989)
    “…IL-6/IFN-beta 2 is a family of phosphoglycoproteins ranging in size from 19 to 30 kDa which elicits a broad range of physiologic and immune responses. Several…”
    Get full text
    Journal Article
  5. 5

    Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid α-interferon in the treatment of established murine hepatic metastases by CAMERON, R. B, MCINTOSH, J. K, ROSENBERG, S. A

    Published in Cancer research (Chicago, Ill.) (15-10-1988)
    “…We investigated the antitumor effects of combined immunotherapy with recombinant human interleukin-2 (rhIL-2) and the recombinant human interferon-alpha…”
    Get full text
    Journal Article
  6. 6

    In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice by McIntosh, JK, Jablons, DM, Mule, JJ, Nordan, RP, Rudikoff, S, Lotze, MT, Rosenberg, SA

    Published in The Journal of immunology (1950) (01-07-1989)
    “…We investigated the capacity of several recombinant cytokines to induce IL-6 in vivo in both normal and tumor-bearing (TB) mice. Intravenous administration of…”
    Get full text
    Journal Article
  7. 7

    Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-α by MCINTOSH, J. K, MULE, J. J, MERINO, M. J, ROSENBERG, S. A

    Published in Cancer research (Chicago, Ill.) (15-07-1988)
    “…The antitumor activity of combination therapy with recombinant tumor necrosis-alpha (rhTNF-alpha) and recombinant interleukin-2 (rhIL-2) was assessed against…”
    Get full text
    Journal Article
  8. 8

    Combination cytokine immunotherapy with tumor necrosis factor α, interleukin 2, and α-interferon and its synergistic antitumor effects in mice by MCINTOSH, J. K, MULE, J. J, KROSNICK, J. A, ROSENBERG, S. A

    Published in Cancer research (Chicago, Ill.) (15-03-1989)
    “…The antitumor activity of combination therapy with recombinant human tumor necrosis factor alpha (rhTNF-alpha), recombinant human interleukin 2 (rhIL-2), and…”
    Get full text
    Journal Article
  9. 9

    Nutritional management of acute and chronic pancreatitis by Latifi, R, McIntosh, J K, Dudrick, S J

    Published in The Surgical clinics of North America (01-06-1991)
    “…Acute pancreatitis often results in a catabolic state characterized by profound hemodynamic, metabolic, cardiovascular, pulmonary, hematologic, and renal…”
    Get more information
    Journal Article
  10. 10

    Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy by HAUSER, G. J, MCINTOSH, J. K, TRAVIS, W. D, ROSENBERG, S. A

    Published in Cancer research (Chicago, Ill.) (15-06-1990)
    “…The role of oxygen free radicals in the toxicity and antitumor effect of tumor necrosis factor was investigated in vivo. Treatment of non-tumor-bearing mice…”
    Get full text
    Journal Article
  11. 11

    Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice by MCINTOSH, J. K, MULE, J. J, TRAVIS, W. D, ROSENBERG, S. A

    Published in Cancer research (Chicago, Ill.) (15-04-1990)
    “…The acute hemorrhagic necrosis of tumor nodules caused by the systemic administration of recombinant human tumor necrosis factor alpha (rhTNF-alpha) has been…”
    Get full text
    Journal Article
  12. 12

    Effect of recombinant human tumor necrosis factor α on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules by EISENTHAL, A, MCINTOSH, J. K

    Published in Cancer Immunology Immunotherapy (01-07-1990)
    “…Incubation of C3H/Hen thymocytes in the presence of recombinant human tumor necrosis factor alpha (TNF) and interleukin-2 (IL-2) augmented the generation of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Studies of the mechanisms of toxicity of the administration of recombinant tumor necrosis factor α in normal and tumor-bearing mice by KROSNICK, J. A, MCINTOSH, J. K, MULE, J. J, ROSENBERG, S. A

    Published in Cancer Immunology Immunotherapy (01-05-1989)
    “…Tumor-bearing mice have a greater sensitivity to the acute lethal effects of the administration of high-dose recombinant human tumor necrosis factor alpha…”
    Get full text
    Journal Article